help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Molecular Endocrinology, doi:10.1210/me.2002-0368
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
17/3/309    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levin, E. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levin, E. R.
Molecular Endocrinology 17 (3): 309-317
Copyright © 2003 by The Endocrine Society

Minireview

Bidirectional Signaling between the Estrogen Receptor and the Epidermal Growth Factor Receptor

Ellis R. Levin

Division of Endocrinology, Long Beach Veterans Affairs Medical Center, Long Beach, California 90822; and Departments of Medicine and Pharmacology, University of California, Irvine, California 92717

Address all correspondence and requests for reprints to: Ellis R. Levin, M.D., Medical Service (111-I), Long Beach Veterans Affairs Medical Center/University of California-Irvine, 5901 East 7th Street, Long Beach, California 90822. E-mail: ellis.levin{at}med.va.gov.

Interactions between the estrogen receptor (ER) and the epidermal growth factor receptor (EGFR) contribute to the biological effects of these binding protein families. EGFR stimulates DNA synthesis and gene transcription in the uterus, related in part to estrogen-independent activation of the nuclear ER. This results from signal transduction enacted by the plasma membrane tyrosine kinase growth factor receptor, leading to 1) phosphorylation and activation of the nuclear ER, and 2) phosphorylation of coregulator proteins. More recently, it has been shown that a pool of ER{alpha} resides in or associates with the plasma membrane as a cytoplasmic protein. These ERs utilize the membrane EGFR to rapidly signal through various kinase cascades that influence both transcriptional and nontranscriptional actions of estrogen in breast cancer cells. This is congruent with a general theme of receptor signaling, where membrane G protein-coupled receptors activate tyrosine kinase growth factor receptors (EGFR, IGF-I receptor) that subsequently signal to MAPKs and other pathways. Overall, the bidirectional cross-talk between EGFR and cellular pools of ER contributes to reproductive organ physiology and pathophysiology.

NURSA Molecule Pages Link:

Nuclear Receptors:   ERα  |  ERβ
Coregulators:   Cyclin D1  |  CBP  |  GRIP1
Ligands:   17β-Estradiol



This article has been cited by other articles:


Home page
 Mol. Endocrinol.Home page
E. M. Fox, T. M. Bernaciak, J. Wen, A. M. Weaver, M. A. Shupnik, and C. M. Silva
Signal Transducer and Activator of Transcription 5b, c-Src, and Epidermal Growth Factor Receptor Signaling Play Integral Roles in Estrogen-Stimulated Proliferation of Estrogen Receptor-Positive Breast Cancer Cells
Mol. Endocrinol., August 1, 2008; 22(8): 1781 - 1796.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
L. Albanito, D. Sisci, S. Aquila, E. Brunelli, A. Vivacqua, A. Madeo, R. Lappano, D. P. Pandey, D. Picard, L. Mauro, et al.
Epidermal Growth Factor Induces G Protein-Coupled Receptor 30 Expression in Estrogen Receptor-Negative Breast Cancer Cells
Endocrinology, August 1, 2008; 149(8): 3799 - 3808.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
B. Tan, X. Long, H. Nakshatri, K. P Nephew, and R. M Bigsby
Striatin-3{gamma} inhibits estrogen receptor activity by recruiting a protein phosphatase
J. Mol. Endocrinol., May 1, 2008; 40(5): 199 - 210.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
O. A. Press, W. Zhang, M. A. Gordon, D. Yang, G. Lurje, S. Iqbal, A. El-Khoueiry, and H.-J. Lenz
Gender-Related Survival Differences Associated with EGFR Polymorphisms in Metastatic Colon Cancer
Cancer Res., April 15, 2008; 68(8): 3037 - 3042.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
G. Arpino, L. Wiechmann, C. K. Osborne, and R. Schiff
Crosstalk between the Estrogen Receptor and the HER Tyrosine Kinase Receptor Family: Molecular Mechanism and Clinical Implications for Endocrine Therapy Resistance
Endocr. Rev., April 1, 2008; 29(2): 217 - 233.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Grossmann, R. Freudinger, S. Mildenberger, B. Husse, and M. Gekle
EF Domains Are Sufficient for Nongenomic Mineralocorticoid Receptor Actions
J. Biol. Chem., March 14, 2008; 283(11): 7109 - 7116.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
R. Dip, S. Lenz, J.-P. Antignac, B. Le Bizec, H. Gmuender, and H. Naegeli
Global gene expression profiles induced by phytoestrogens in human breast cancer cells
Endocr. Relat. Cancer, March 1, 2008; 15(1): 161 - 173.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Massarweh, C. K. Osborne, C. J. Creighton, L. Qin, A. Tsimelzon, S. Huang, H. Weiss, M. Rimawi, and R. Schiff
Tamoxifen Resistance in Breast Tumors Is Driven by Growth Factor Receptor Signaling with Repression of Classic Estrogen Receptor Genomic Function
Cancer Res., February 1, 2008; 68(3): 826 - 833.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
S. R. Hammes and E. R. Levin
Extranuclear Steroid Receptors: Nature and Actions
Endocr. Rev., December 1, 2007; 28(7): 726 - 741.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
V. Pelekanou, M. Kampa, M. Kafousi, K. Dambaki, K. Darivianaki, T. Vrekoussis, E. Sanidas, D. D. Tsiftsis, E. N. Stathopoulos, and E. Castanas
Erythropoietin and Its Receptor in Breast Cancer: Correlation with Steroid Receptors and Outcome
Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 2016 - 2023.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
B. M. Wittmann, A. Sherk, and D. P. McDonnell
Definition of Functionally Important Mechanistic Differences among Selective Estrogen Receptor Down-regulators
Cancer Res., October 1, 2007; 67(19): 9549 - 9560.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
C. Wang, E. R. Prossnitz, and S. K. Roy
Expression of G Protein-Coupled Receptor 30 in the Hamster Ovary: Differential Regulation by Gonadotropins and Steroid Hormones
Endocrinology, October 1, 2007; 148(10): 4853 - 4864.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
W. Fiskus, Y. Ren, A. Mohapatra, P. Bali, A. Mandawat, R. Rao, B. Herger, Y. Yang, P. Atadja, J. Wu, et al.
Hydroxamic Acid Analogue Histone Deacetylase Inhibitors Attenuate Estrogen Receptor-{alpha} Levels and Transcriptional Activity: A Result of Hyperacetylation and Inhibition of Chaperone Function of Heat Shock Protein 90
Clin. Cancer Res., August 15, 2007; 13(16): 4882 - 4890.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Majidi, H. A. Al-Wadei, T. Takahashi, and H. M. Schuller
Nongenomic {beta} Estrogen Receptors Enhance {beta}1 Adrenergic Signaling Induced by the Nicotine-Derived Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone in Human Small Airway Epithelial Cells
Cancer Res., July 15, 2007; 67(14): 6863 - 6871.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
C. M. Silva and M. A. Shupnik
Integration of Steroid and Growth Factor Pathways in Breast Cancer: Focus on Signal Transducers and Activators of Transcription and Their Potential Role in Resistance
Mol. Endocrinol., July 1, 2007; 21(7): 1499 - 1512.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
N. Levy, X. Zhao, H. Tang, R. B. Jaffe, T. P. Speed, and D. C. Leitman
Multiple Transcription Factor Elements Collaborate with Estrogen Receptor {alpha} to Activate an Inducible Estrogen Response Element in the NKG2E Gene
Endocrinology, July 1, 2007; 148(7): 3449 - 3458.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
G. I. Gorodeski
Estrogen Modulation of MgATPase Activity of Nonmuscle Myosin-II-B Filaments
Endocrinology, January 1, 2007; 148(1): 279 - 292.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
X. Li and G. Gorodeski
Non-Muscle Myosin-II-B Filament Regulation of Paracellular Resistance in Cervical Epithelial Cells Is Associated With Modulation of the Cortical Acto-Myosin
Reproductive Sciences, December 1, 2006; 13(8): 579 - 591.
[Abstract] [PDF]

Home page
 Endocr Relat CancerHome page
R. X-D Song, P. Fan, W. Yue, Y. Chen, and R. J Santen
Role of receptor complexes in the extranuclear actions of estrogen receptor {alpha} in breast cancer
Endocr. Relat. Cancer, December 1, 2006; 13(Supplement_1): S3 - S13.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
X. Li, L. Zhou, and G. I. Gorodeski
Estrogen Regulates Epithelial Cell Deformability by Modulation of Cortical Actomyosin through Phosphorylation of Nonmuscle Myosin Heavy-Chain II-B Filaments
Endocrinology, November 1, 2006; 147(11): 5236 - 5248.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
V. C. Jordan
The Science of Selective Estrogen Receptor Modulators: Concept to Clinical Practice
Clin. Cancer Res., September 1, 2006; 12(17): 5010 - 5013.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
B. Moy and P. E. Goss
Estrogen Receptor Pathway: Resistance to Endocrine Therapy and New Therapeutic Approaches.
Clin. Cancer Res., August 15, 2006; 12(16): 4790 - 4793.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
T. Buterin, C. Koch, and H. Naegeli
Convergent transcriptional profiles induced by endogenous estrogen and distinct xenoestrogens in breast cancer cells
Carcinogenesis, August 1, 2006; 27(8): 1567 - 1578.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
R. X.-D. Song and R. J. Santen
Membrane Initiated Estrogen Signaling in Breast Cancer
Biol Reprod, July 1, 2006; 75(1): 9 - 16.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
T. Yaoi, S. Chamnongpol, X. Jiang, and X. Li
Src Homology 2 Domain-based High Throughput Assays for Profiling Downstream Molecules in Receptor Tyrosine Kinase Pathways
Mol. Cell. Proteomics, May 1, 2006; 5(5): 959 - 968.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Biol.Home page
O. Sukocheva, C. Wadham, A. Holmes, N. Albanese, E. Verrier, F. Feng, A. Bernal, C. K. Derian, A. Ullrich, M. A. Vadas, et al.
Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: the role of sphingosine kinase-1
J. Cell Biol., April 24, 2006; 173(2): 301 - 310.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. D. Yager and N. E. Davidson
Estrogen Carcinogenesis in Breast Cancer
N. Engl. J. Med., January 19, 2006; 354(3): 270 - 282.
[Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
N. Normanno, M. Di Maio, E. De Maio, A. De Luca, A. de Matteis, A. Giordano, F. Perrone, and on behalf of the NCI-Naples Breast Cancer Group
Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer
Endocr. Relat. Cancer, December 1, 2005; 12(4): 721 - 747.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Migliaccio, M. Di Domenico, G. Castoria, M. Nanayakkara, M. Lombardi, A. de Falco, A. Bilancio, L. Varricchio, A. Ciociola, and F. Auricchio
Steroid Receptor Regulation of Epidermal Growth Factor Signaling through Src in Breast and Prostate Cancer Cells: Steroid Antagonist Action
Cancer Res., November 15, 2005; 65(22): 10585 - 10593.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
J. L. Boerner, M. A. Gibson, E. M. Fox, E. D. Posner, S. J. Parsons, C. M. Silva, and M. A. Shupnik
Estrogen Negatively Regulates Epidermal Growth Factor (EGF)-Mediated Signal Transducer and Activator of Transcription 5 Signaling in Human EGF Family Receptor-Overexpressing Breast Cancer Cells
Mol. Endocrinol., November 1, 2005; 19(11): 2660 - 2670.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
F. F. Zheng, R.-C. Wu, C. L. Smith, and B. W. O'Malley
Rapid Estrogen-Induced Phosphorylation of the SRC-3 Coactivator Occurs in an Extranuclear Complex Containing Estrogen Receptor
Mol. Cell. Biol., September 15, 2005; 25(18): 8273 - 8284.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. K. Vadlamudi, B. Manavathi, S. Balasenthil, S. S. Nair, Z. Yang, A. A. Sahin, and R. Kumar
Functional Implications of Altered Subcellular Localization of PELP1 in Breast Cancer Cells
Cancer Res., September 1, 2005; 65(17): 7724 - 7732.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
T. Takahashi, M. Ohmichi, J. Kawagoe, C. Ohshima, M. Doshida, T. Ohta, M. Saitoh, A. Mori-Abe, B. Du, H. Igarashi, et al.
Growth Factors Change Nuclear Distribution of Estrogen Receptor-{alpha} via Mitogen-Activated Protein Kinase or Phosphatidylinositol 3-Kinase Cascade in a Human Breast Cancer Cell Line
Endocrinology, September 1, 2005; 146(9): 4082 - 4089.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
J. H. Gutzman, S. E. Nikolai, D. E. Rugowski, J. J. Watters, and L. A. Schuler
Prolactin and Estrogen Enhance the Activity of Activating Protein 1 in Breast Cancer Cells: Role of Extracellularly Regulated Kinase 1/2-Mediated Signals to c-fos
Mol. Endocrinol., July 1, 2005; 19(7): 1765 - 1778.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
C. Grossmann, A. Benesic, A. W. Krug, R. Freudinger, S. Mildenberger, B. Gassner, and M. Gekle
Human Mineralocorticoid Receptor Expression Renders Cells Responsive for Nongenotropic Aldosterone Actions
Mol. Endocrinol., July 1, 2005; 19(7): 1697 - 1710.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. D. Patel
Lung Cancer in Women
J. Clin. Oncol., May 10, 2005; 23(14): 3212 - 3218.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
N. Kanda and S. Watanabe
17{beta}-Estradiol enhances heparin-binding epidermal growth factor-like growth factor production in human keratinocytes
Am J Physiol Cell Physiol, April 1, 2005; 288(4): C813 - C823.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C. K. Osborne and R. Schiff
Estrogen-Receptor Biology: Continuing Progress and Therapeutic Implications
J. Clin. Oncol., March 10, 2005; 23(8): 1616 - 1622.
[Full Text] [PDF]

Home page
 Mol Cancer ResHome page
S. Banerjee, K. Sengupta, N. K. Saxena, K. Dhar, and S. K. Banerjee
Epidermal Growth Factor Induces WISP-2/CCN5 Expression in Estrogen Receptor-{alpha}-Positive Breast Tumor Cells through Multiple Molecular Cross-talks
Mol. Cancer Res., March 1, 2005; 3(3): 151 - 162.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. P. Stabile, J. S. Lyker, C. T. Gubish, W. Zhang, J. R. Grandis, and J. M. Siegfried
Combined Targeting of the Estrogen Receptor and the Epidermal Growth Factor Receptor in Non-Small Cell Lung Cancer Shows Enhanced Antiproliferative Effects
Cancer Res., February 15, 2005; 65(4): 1459 - 1470.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. A. Hershberger, A. C. Vasquez, B. Kanterewicz, S. Land, J. M. Siegfried, and M. Nichols
Regulation of Endogenous Gene Expression in Human Non-Small Cell Lung Cancer Cells by Estrogen Receptor Ligands
Cancer Res., February 15, 2005; 65(4): 1598 - 1605.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Q. Lu, D. C. Pallas, H. K. Surks, W. E. Baur, M. E. Mendelsohn, and R. H. Karas
Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor {alpha}
PNAS, December 7, 2004; 101(49): 17126 - 17131.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
M. Razandi, A. Pedram, I. Merchenthaler, G. L. Greene, and E. R. Levin
Plasma Membrane Estrogen Receptors Exist and Functions as Dimers
Mol. Endocrinol., December 1, 2004; 18(12): 2854 - 2865.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
M. Razandi, A. Pedram, E. M. Rosen, and E. R. Levin
BRCA1 Inhibits Membrane Estrogen and Growth Factor Receptor Signaling to Cell Proliferation in Breast Cancer
Mol. Cell. Biol., July 1, 2004; 24(13): 5900 - 5913.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
R. I. Fernando and J. Wimalasena
Estradiol Abrogates Apoptosis in Breast Cancer Cells through Inactivation of BAD: Ras-dependent Nongenomic Pathways Requiring Signaling through ERK and Akt
Mol. Biol. Cell, July 1, 2004; 15(7): 3266 - 3284.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
K. Sengupta, S. Banerjee, N. K. Saxena, and S. K. Banerjee
Thombospondin-1 Disrupts Estrogen-Induced Endothelial Cell Proliferation and Migration and Its Expression Is Suppressed by Estradiol
Mol. Cancer Res., March 1, 2004; 2(3): 150 - 158.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
D.-b. Chen, I. M. Bird, J. Zheng, and R. R. Magness
Membrane Estrogen Receptor-Dependent Extracellular Signal-Regulated Kinase Pathway Mediates Acute Activation of Endothelial Nitric Oxide Synthase by Estrogen in Uterine Artery Endothelial Cells
Endocrinology, January 1, 2004; 145(1): 113 - 125.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. S. Foster, R. I. Fernando, N. Ishida, K. I. Nakayama, and J. Wimalasena
Estrogens Down-regulate p27Kip1 in Breast Cancer Cells through Skp2 and through Nuclear Export Mediated by the ERK Pathway
J. Biol. Chem., October 17, 2003; 278(42): 41355 - 41366.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society